India · Delayed Price · Currency is INR Glenmark Pharmaceuticals Statistics
Total Valuation
BOM:532296 has a market cap or net worth of INR 563.72 billion. The enterprise value is 549.06 billion.
| Market Cap | 563.72B |
| Enterprise Value | 549.06B |
Important Dates
The last earnings date was Friday, January 30, 2026.
| Earnings Date | Jan 30, 2026 |
| Ex-Dividend Date | Oct 3, 2025 |
Share Statistics
| Current Share Class | 282.20M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.04% |
| Shares Change (QoQ) | +0.02% |
| Owned by Insiders (%) | 3.12% |
| Owned by Institutions (%) | 37.71% |
| Float | 141.49M |
Valuation Ratios
The trailing PE ratio is 52.93 and the forward PE ratio is 25.68.
| PE Ratio | 52.93 |
| Forward PE | 25.68 |
| PS Ratio | 3.41 |
| PB Ratio | 5.88 |
| P/TBV Ratio | 7.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 51.55 |
| EV / Sales | 3.33 |
| EV / EBITDA | 13.30 |
| EV / EBIT | 14.22 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.13 |
| Debt / EBITDA | 0.30 |
| Debt / FCF | n/a |
| Interest Coverage | 16.59 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 31.58% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 10.45M |
| Profits Per Employee | 674,106 |
| Employee Count | 15,800 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BOM:532296 has paid 5.40 billion in taxes.
| Income Tax | 5.40B |
| Effective Tax Rate | 33.64% |
Stock Price Statistics
The stock price has increased by +44.59% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +44.59% |
| 50-Day Moving Average | 1,992.79 |
| 200-Day Moving Average | 1,881.06 |
| Relative Strength Index (RSI) | 51.63 |
| Average Volume (20 Days) | 13,564 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:532296 had revenue of INR 165.10 billion and earned 10.65 billion in profits. Earnings per share was 37.74.
| Revenue | 165.10B |
| Gross Profit | 116.74B |
| Operating Income | 38.62B |
| Pretax Income | 16.05B |
| Net Income | 10.65B |
| EBITDA | 40.30B |
| EBIT | 38.62B |
| Earnings Per Share (EPS) | 37.74 |
Balance Sheet
The company has 26.90 billion in cash and 12.24 billion in debt, with a net cash position of 14.66 billion.
| Cash & Cash Equivalents | 26.90B |
| Total Debt | 12.24B |
| Net Cash | 14.66B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 95.82B |
| Book Value Per Share | 339.57 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 70.71%, with operating and profit margins of 23.39% and 6.45%.
| Gross Margin | 70.71% |
| Operating Margin | 23.39% |
| Pretax Margin | 9.72% |
| Profit Margin | 6.45% |
| EBITDA Margin | 24.41% |
| EBIT Margin | 23.39% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.25%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | 100.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | n/a |
| Buyback Yield | -0.04% |
| Shareholder Yield | 0.20% |
| Earnings Yield | 1.89% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 10, 2007. It was a forward split with a ratio of 2.
| Last Split Date | Sep 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |